ACE and metabolic syndrome: It has been suggested that activation of RAS through insulin resistance may cause the development of dyslipidemia and diabetes which was supported by finding that ACE inhibitors were able to reduce the lipolysis induced by insulin resistance in adipose tissues of centrally obese hypertensive individuals [35].